Le Lézard
Classified in: Health
Subject: MRR

Intraocular Lens (IOL) Market to Grow Phenomenally by 2029- Brandessence Market Research

LONDON, May 29, 2023 /PRNewswire/ -- Intraocular lenses are predominantly used to replace the natural eye lens of individuals with cataract. This ocular condition causes the natural eye lens to lose its transparency or become cloudy, causing blurry vision and other issues. Intraocular lenses and predominantly made of biocompatible materials, such as silicone or acrylic, and are surgically implanted in place of natural eye lens. These lenses are equipped with the ability to focus light on the retina and enhance vision. Apart from cataract, these lenses can also be used in conditions like long sightedness or short sightedness.


The business intelligence report on Intraocular Lens (IOL) Market by Brandessence Market Research is specially curated with an aim to provide the industry participants with valuable insights on this business sphere. It covers various essential aspects, including market size, growth drivers, challenges, trends, and opportunities. It offers a thorough examination of the market segmentation based on type, material, and end-user. It further highlights the market's regional analysis, providing a detailed understanding of the market performance across key geographical regions. In addition, it presents a detailed analysis of the key players operating in the market, their product portfolios, business strategies, and recent developments.

Key Takeaways

The Intraocular Lens (IOL) Market is anticipated to garner significant returns over the assessment timeline of 2022-2029.

Get Sample of Report@ https://brandessenceresearch.com/downloadSample/PostId/282

Elaborating the Key Trends and Dynamics of Intraocular Lens (IOL) Market

Growing prevalence of ocular disorders, increased screen time of individuals, and widespread technological advancements in the field are primarily augmenting the outlook of this business sphere. Alongside, rise in the number of cataract surgeries, surge in the elderly populace, along with the increasing R&D activities in the field are creating lucrative opportunities for this marketplace to prosper. Moreover, increasing awareness on eye related disorders among the masses, changing lifestyle trends, and rise in healthcare expenditure are adding momentum to the progression of this industry vertical.

Major Growth Drivers

Growing occurrence of cataract- Cataract, a vision related disorder has become highly prevalent across the globe. If not treated on time, it might lead to permanent blindness. Rise in the geriatric population, unhealthy lifestyle trends, and exposure to toxins are some of the pivotal factors leading to the onset of this disorder. As cataract is commonly treated with surgery, the demand for intraocular lenses is expected to rise to meet the growing surgical needs.

High awareness about the benefits of Premium IOL- Premium Intraocular Lens are gaining immense prominence among the masses. This is due to the growing cognizance about its benefits. Apart from basic vision correction, these lenses are equipped with multifocal, toric, and accommodative capabilities. They reduce the need of glasses or contact lenses after cataract surgery. This in turn is stimulating the overall dynamics of this business vertical.


Risk of complications- Even though intraocular lens implantation is quite safe and effective, but there is certain risk of complications associated with them. There are chances of infection, inflammation, posterior capsule opacification, or dislocation of the lens which might further affect the vision of the patient. These factors are hindering the remuneration scope of this market.

Competitive landscape of Intraocular Lens (IOL) Market

The prominent players defining the competitive terrain of this business vertical are Abbott Medical Optics, Carl Zeiss Meditec AG, Johnson & Johnson, Alcon, Eyekon Medical, Lenstec, STAAR Surgical Company, Rayner Intraocular Lenses Limited, HumanOptics AG, Bausch & Lomb Incorporated, Calhoun Vision, Hoya Corporation, Aurolab, Care Group, Tekia Inc., Omni Lens Pvt Ltd., MORCHER® GmbH, Ophtec BV, SIFI S.p.A., Excellent Hi-Care Pvt. Ltd., Hanita Lenses, and Others.

Segmental assessment

By type, the monofocal intraocular lens segment is anticipated to amass notable gains over 2022-2029 due to their affordability and their rising adoption in cataract surgeries.

Based on material, the PMMA segment is slated to garner significant returns over the estimated timeframe. This is ascribed to its cost effectiveness as compared to other materials.

Get Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/282

Geographical Analysis and Landscape

Middle East & Africa Intraocular Lens (IOL) Market

MEA is projected to capture a substantial market share over the stipulated timeline. This is attributable to the increased healthcare expenditure, rapidly evolving medical infrastructure, and the surging prevalence of ocular disorders. Besides, rise in the geriatric population base, technological advances, and growing awareness about the benefits of these lenses are adding traction to the progression of this business sphere.


Europe is poised to showcase the fastest growth over 2022-2029. This is supported by the changing lifestyle trends of the masses, increased screen timings of individuals, and presence of noteworthy players. Alongside, rising R&D activities, surge in elderly populace, and the presence of an ideal medical reimbursement scenario are propelling market growth in this region.

Opportunities in This Industry

Technological innovations- There have widespread technological advancements in the field of ophthalmology.  Innovative technologies are being used in surgical techniques to enhance their efficiency and safety. This in turn is creating profitable prospects for this market.

Major Developments in Intraocular Lens (IOL) Market


In 2020, Carl Zeiss Meditec, a provider of ophthalmic devices and solutions announced the acquisition of prominent US based intraocular lenses and ophthalmic surgical instruments manufacturer, Aaren Scientific.

In 2021, Alcon announced the acquisition of a fluid-based intraocular lens technology developer named PowerVision.

Porter's Five Forces Analysis

Threat of new entrants:  The threat of new entrants in the intraocular lens market is relatively low. The industry requires significant investments in research and development, manufacturing capabilities, and regulatory compliance. Additionally, stringent regulatory requirements and intellectual property rights protection further deter new entrants.

Bargaining Power of Suppliers: Suppliers in the intraocular lens market, such as raw material providers and manufacturing equipment suppliers, generally have moderate bargaining power. While there may be multiple suppliers available, the market requires adherence to strict quality standards and regulatory compliance. In cases where suppliers have unique and critical technology or expertise, their bargaining power may be higher. However, the presence of multiple suppliers and the ability of manufacturers to swich suppliers mitigate supplier power to some extent.

Bargaining Power of Buyers: Buyers in the intraocular lens market, including hospitals, clinics, and ophthalmologists, have moderate to high bargaining power. Buyers can compare and evaluate different intraocular lens options based on factors such as quality, cost, and features. Moreover, with the availability of various manufacturers and product options, buyers have the flexibility to negotiate prices and terms. However, the importance of product quality and reliability often supersedes price considerations, giving manufacturers some leverage.

Threat of Substitutes: The threat of substitutes in the intraocular lens market is relatively low. Intraocular lenses are the standard and most effective treatment for cataract patients who require lens replacement. While there are alternative vision correction methods such as glasses and contact lenses, they do not provide the same level of visual improvement as intraocular lenses.

Competitive Rivalry: The intraocular lens market is highly competitive, with several key players vying for market share. Intense competition exists in terms of product offerings, technological advancements, pricing strategies, and distribution networks. Market leaders invest in research and development to introduce innovative intraocular lens designs and technologies, further driving competition.

On Special Requirement Acute Repetitive Seizures Market Report is also available for below region:

North America                                                                                           



Latin America

Middle East and Africa

Purchase Copy of Report @ https://brandessenceresearch.com/Checkout?report_id=282

Related Reports:

Brandessence Market Research & Consulting Pvt ltd. 

Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in?Pune, India?and our sales office is in?London. 

Follow Us:?Linkedin ?

M & A Advisory: Merger & Acquisition, and Capabilities

Mr.?Vishal Sawant? 
Email:?[email protected]
Email:?[email protected]
Corporate Sales:?+44-2038074155? 
Asia Office:?+917447409162 

Logo: https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg


These press releases may also interest you

at 06:29
On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to participate in the YL201 Phase I/II Investigators Meeting hosted by Suzhou MediLink Therapeutics Co., Ltd. The...

22 sep 2023
Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of HANSIZHUANG (serplulimab injection), an innovative anti-PD-1 monoclonal antibody independently developed by the company, in combination with...

22 sep 2023
The "Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech)" report has been...

22 sep 2023
The "Global IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Forecast...

22 sep 2023
ResearchAndMarkets.com announces the 4th Annual Orphan Drugs and Rare Diseases Conference, scheduled for October 9-10 in London, UK. This prestigious event offers an in-depth exploration into the ever-evolving world of orphan drugs, post the landmark...

22 sep 2023
The "Global LASIK Eye Surgery Devices Market" report has been added to  ResearchAndMarkets.com's offering.  Global LASIK eye surgery devices market is projected to reach a value of $3.7 billion by 2028 from $2.7 billion in 2023, growing at a CAGR of...

News published on and distributed by: